Information:
Error:
ID
34260
Description
Efficacy and Safety Study of ELIGARD 22.5mg With Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01511874
Link
https://clinicaltrials.gov/show/NCT01511874
Keywords
Versions (1)
- 1/16/19 1/16/19 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
January 16, 2019
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Prostate Cancer NCT01511874
Eligibility Prostate Cancer NCT01511874
- StudyEvent: Eligibility
Similar models
Eligibility Prostate Cancer NCT01511874
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Gender | Age
Item
male of 20 years or above
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
Prostate carcinoma TNM Prostate tumor staging
Item
subject with prostate cancer with tnm stage t2~4nxmx
boolean
C0600139 (UMLS CUI [1,1])
C0474935 (UMLS CUI [1,2])
C0474935 (UMLS CUI [1,2])
Blood testosterone measurement
Item
blood testosterone concentration ≥ 100ng/dl
boolean
C0853134 (UMLS CUI [1])
Serum total bilirubin measurement | Transaminases Measurement
Item
bilirubin ≤ 1.5xuln, transaminase ≤ 2.5xuln
boolean
C1278039 (UMLS CUI [1])
C0002594 (UMLS CUI [2,1])
C0242485 (UMLS CUI [2,2])
C0002594 (UMLS CUI [2,1])
C0242485 (UMLS CUI [2,2])
WHO performance status scale | ECOG performance status
Item
who ecog performance status ≤ 2
boolean
C1298650 (UMLS CUI [1])
C1520224 (UMLS CUI [2])
C1520224 (UMLS CUI [2])
Informed Consent
Item
signed written informed consent
boolean
C0021430 (UMLS CUI [1])
Hormone refractory prostate cancer
Item
hormone-refractory prostate cancer
boolean
C1328504 (UMLS CUI [1])
Metastatic malignant neoplasm to brain
Item
brain metastasis
boolean
C0220650 (UMLS CUI [1])
Primary tumor Other | Exception Prostate carcinoma
Item
another primary malignant tumor except for prostate cancer
boolean
C0677930 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0600139 (UMLS CUI [2,2])
C0205394 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0600139 (UMLS CUI [2,2])
Condition Study Subject Participation Status Excluded
Item
other conditions which in the opinion of the investigator preclude enrollment into the study
boolean
C0348080 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C0332196 (UMLS CUI [1,3])
C2348568 (UMLS CUI [1,2])
C0332196 (UMLS CUI [1,3])